ArticleMolecular cancer therapeutics2025

Tumor Integrin-Targeted Glucose Oxidase Enzyme Promotes ROS-Mediated Cell Death that Combines with Interferon Alpha Therapy for Tumor Control.

Jordan A Stinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.